Weight-based, anti-Xa guided enoxaparin after spine trauma surgery: target attainment and safety in a retrospective cohort - Summary - MDSpire

Weight-based, anti-Xa guided enoxaparin after spine trauma surgery: target attainment and safety in a retrospective cohort

  • By

  • Dallas L. Sheinberg

  • David Travis Johnston

  • Brendan T. O'Reilly

  • Gabriel Galan Castro

  • Jawad R. Khazaal

  • Joseph S. Withrow

  • Duncan J. Trimble

  • Ankush Chandra

  • Anthony J. Lim

  • Derek S. Sheinberg

  • Jennifer Zaragoza

  • Wen Li

  • John R. Williams

  • June 24, 2026

  • 0 min

Share

Objective:

To evaluate anti-Xa target attainment, symptomatic VTE, and safety outcomes after anti-Xa-guided enoxaparin titration in postoperative spine trauma patients.

Approach:
  • Comparison: A comparison cohort received the same initial dosing without anti-Xa monitoring, allowing for a direct comparison of outcomes.
Key Findings:
  • Symptomatic VTE was rare and similar between anti-Xa and fixed dose groups (1.1% vs. 1.6%).
  • No postoperative epidural hematomas occurred.
  • 28% of the anti-Xa cohort required dose escalation, with 7% needing more than one adjustment.
  • Bleeding requiring transfusion and length of stay did not differ between groups.
Interpretation:

Weight-based enoxaparin with anti-Xa-guided titration was feasible and identified patients below the prophylactic anti-Xa target range without increasing bleeding risks.

Limitations:
  • Retrospective design may introduce bias.
  • Findings are based on a single trauma center, limiting generalizability.
Conclusion:

Further research is necessary to explore the relationship between anti-Xa target attainment and VTE rates.

Original Source(s)

Related Content